Decreased iKIR-HLA C Pair Confers Worse Clinical Outcomes for Patients With Myeloid Disease Receiving Antithymocyte Globulin-Based Haploidentical Hematopoietic Stem Cell Transplantation

Hematopoietic stem cell transplantation (HSCT) is a curative therapy for patients with malignant hematologic diseases. Killer immunoglobin-like receptor (KIR) expressed by NK cells is closely associated with the transplant outcomes, and it has been widely explored and debated for a few decades. Rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yanmin, Gao, Fei, Wu, Yibo, Shi, Jimin, Luo, Yi, Tan, Yamin, Yu, Jian, Lai, Xiaoyu, Zhang, Mingming, Zhang, Wei, Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901980/
https://www.ncbi.nlm.nih.gov/pubmed/33633734
http://dx.doi.org/10.3389/fimmu.2020.614488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901980/
https://www.ncbi.nlm.nih.gov/pubmed/33633734
http://dx.doi.org/10.3389/fimmu.2020.614488

Ejemplares similares